| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |